Compounds > nylidrin
Page last updated: 2024-11-01

nylidrin and Age-Related Macular Degeneration

nylidrin has been researched along with Age-Related Macular Degeneration in 2 studies

Nylidrin: A beta-adrenergic agonist. Nylidrin causes peripheral vasodilation, a positive inotropic effect, and increased gastric volume of gastric juice. It is used in the treatment of peripheral vascular disorders and premature labor.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bartlett, H1
Eperjesi, F1
Kaiser, HJ1
Flammer, J1
Stümpfig, D1
Hendrickson, P1

Reviews

1 review available for nylidrin and Age-Related Macular Degeneration

ArticleYear
Age-related macular degeneration and nutritional supplementation: a review of randomised controlled trials.
    Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists), 2003, Volume: 23, Issue:5

    Topics: alpha-Tocopherol; Antioxidants; Ascorbic Acid; beta Carotene; Carotenoids; Dietary Supplements; Drug

2003

Trials

1 trial available for nylidrin and Age-Related Macular Degeneration

ArticleYear
Visaline in the treatment of age-related macular degeneration: a pilot study.
    Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 1995, Volume: 209, Issue:6

    Topics: Adrenergic beta-Agonists; Aged; alpha-Tocopherol; Antioxidants; Ascorbic Acid; beta Carotene; Double

1995